Illness	Number of cases
Malignant neoplasm of bronchus and lung (C34.1)	425
Malignant neoplasm of bronchus and lung (C34.3)	191
Malignant neoplasm of bronchus and lung (C34.0)	82
Malignant neoplasm of bronchus and lung (C34.8)	53
Malignant neoplasm of bronchus and lung - Malignant neoplasm of middle lobe bronchus or lung (C34.2)	36
Malignant neoplasm of bronchus and lung (C34.9)	13
Neoplasm of uncertain or unknown behaviour of middle ear and respiratory and intrathoracic organs - Neoplasm of uncertain behavior of trachea bronchus and lung (D38.1)	10
Malignant neoplasm of thymus (C37)	7
Pneumonia organism unspecified - Pneumonia unspecified organism (J18.9)	7
Malignant neoplasm without specification of site - Disseminated malignant neoplasm unspecified (C80.0)	6

Top 10 treatments

Treatment	Number
Administration of medicines in accordance with List 2 of the procedures list (6-002.72)	499
Specific psychotherapeutic procedure where patients are treated individually - individual therapy (9-410.x)	411
Examination of the trachea and the bronchi by endoscopy (1-620.00)	315
Others therapeutic procedures to influence the immune system (8-547.0)	314
Analysis of the amount of carbon monoxide taken in and given off by the lungs (1-711)	300
Measurement of lung function in an airtight cabin - whole body plethysmography (1-710)	295
Cancer treatment for one or more days with chemotherapy drugs administered into a vein or beneath the skin (8-542.12)	283
(9-984.b)	231
Uniform basic assessment in terminal care (1-774)	211
Cancer treatment for several days (e.g. 2-4 days) with two or more chemotherapy drugs administered into a vein (8-543.32)	208

Further information about the department

Out-patient accident insurance doctor approval

In-patient Employers’ Liability Insurance Association approval

Department key

Department key: 0800

Type of specialist department

Main Department

Hospital information and services for all specialist departments

Services

Quality

External comparative quality assurance

Further information

External quality assurance according to state law
No participation

Quality of participation in the Disease Management Programme (DMP)
No participation

Teilnahme an sonstigen Verfahren der externen vergleichenden Qualitätssicherung

Implementation of resolutions of the Federal Joint Committee on quality assurance (G-BA)
No participation

Further training
pursuant to Article 136b, para. 1, sentence 1, no. 1 of the SGB

Number	Group
71	Medical specialists (m/f) , psychological psychotherapists (m/f) and child and adolescent psychotherapists (m/f) who are subject to the obligation to undergo further training*
14	Number of medical specialists (m/f) from no. 1 who have completed a five-year period of further training and are therefore subject to the obligation to provide evidence
14	Number of those persons from no. 2 who have provided proof of further training according to Article 3 of the G-BA regulations

* according to the “Provisions of the Joint Federal Committee for the Further Training of Medical Specialists (m/f), Psychological Psychotherapists (m/f) and Child and Adolescent Psychotherapists (m/f) in Hospitals”

Accessibility

Accessibility information

General information

Research & teaching

Job	Explanation
Initiation and management of uni-centric/multi-centric clinical/scientific studies
Editors of scientific journals/textbooks
Doctoral supervision
Student training (clinical traineeship / internship year)	Famulaturen
Project-related cooperation with colleges and universities
Participation in multi-centre phase III/IV studies